Clearpoint Neuro Inc (CLPT) - News Archive

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million NoteClearPoint Neuro, a leading therapeutic neuro-navigation system provider, has made a significant stride towards improving its financial...

ClearPoint Neuro, a global leader in intraoperative neurosurgical planning and navigation solutions, is pleased to announce a significant milestone achieved by its valued partner, Aspen Neuroscience. The renowned ClearP...

Rapid Advances in Neurosurgical Technology Drive Revenue Growth for ClearPoint Neuro Inc. ClearPoint Neuro, a leading provider of innovative medical devices for neurological procedures, recently announced the full marke...

ClearPoint Neuro, Inc., a leading innovator in bio-navigational systems, has firmly positioned itself at the forefront of gene and cell therapy research with groundbreaking projects. Preeminent among these are novel dru...

ClearPoint Neuro, a health-tech company focusing on innovative neurological treatments and tools, recently gained the US Food and Drug Administration (FDA) clearance for its Prism Bone Anchor Accessory. This clearance i...

ClearPoint Neuro, a leading medical technology company, has recently made significant advancements in its SmartFrame OR Stereotactic System. This cutting-edge system has successfully completed its first ten operating ro...

Topical Therapy Shows Promising Results in Preclinical Skin Cancer Trial: A Potential Breakthrough in Preventing and Treating Skin CancersThe incidence of precancerous skin conditions and skin cancers is on the rise glo...

ClearPoint Neuro, a leading provider of interventional MRI devices, congratulates its partner AviadoBio on successfully treating the first patient in the ASPIRE-FTD clinical trial. This groundbreaking trial aims to eval...

ClearPoint Neuro Continues to Make Significant Strides in Neurological Treatment AdvancesClearPoint Neuro, a leading medical technology company, recently celebrated a major milestone achieved by its partner, PTC Therape...

Journal of Neurosurgery Publication Highlights ClearPoint Prism Neuro Laser Therapy System s Unparalleled Efficiency and PrecisionIn an exciting development, ClearPoint Neuro has recently released a peer-reviewed public...

SOLANA BEACH, Calif., Feb. 29, 2024 - ClearPoint Neuro, Inc. (Nasdaq: CLPT), a pioneering global medical device, cell, and gene therapy-enabling company, has recently announced the pricing of its underwritten public off...

ClearPoint Neuro, Inc. Announces Proposed Public Offering of Common StockClearPoint Neuro, Inc., a leading global device, cell, and gene therapy-enabling company specializing in precise navigation to the brain and spine...

ClearPoint Neuro, a leading medical technology company specializing in advanced neuroscience solutions, has recently achieved a series of significant milestones that are set to transform the field of neurosurgery. The c...

In a monumental leap forward for neurosurgical procedures, ClearPoint Neuro has announced the successful installation and first procedure using the pioneering ClearPoint Prism Neuro Laser Therapy System and Navigation S...

ClearPoint Neuro, a leading medical technology company based in Carlsbad, California, has recently achieved a significant milestone by obtaining its first European Union Medical Device Regulation (EU MDR) certification....